Pivotal Research Upgrades Facebook (FB) to Buy; Recent Weakness Offers Opportunity
Tweet
Share
E-mailGet Alerts FB Hot Sheet
Price: $45.08 --0%
Rating Summary:
46 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Rating Summary:
46 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Join SI Premium – FREE
Pivotal Research upgraded Facebook (NASDAQ: FB) from Hold to Buy with a price target of $33.00.
Analyst, Brian Wieser, said, "Our price target on Facebook is largely driven by our expectations for rising revenue growth, weakening operating margins, rising capital expenditures and accounting for a riskier business profile when compared with the stock’s closest peer, Google (Nasdaq: GOOG)(BUY). This valuation has been and remains driven by fundamental factors. Our estimates on advertising revenues – which account for more than 80% of the company’s revenue – are based on ongoing interactions with scores of marketers and advertising agency professionals."
For an analyst ratings summary and ratings history on Facebook click here. For more ratings news on Facebook click here.
Shares of Facebook closed at $29.34 yesterday.
Analyst, Brian Wieser, said, "Our price target on Facebook is largely driven by our expectations for rising revenue growth, weakening operating margins, rising capital expenditures and accounting for a riskier business profile when compared with the stock’s closest peer, Google (Nasdaq: GOOG)(BUY). This valuation has been and remains driven by fundamental factors. Our estimates on advertising revenues – which account for more than 80% of the company’s revenue – are based on ongoing interactions with scores of marketers and advertising agency professionals."
For an analyst ratings summary and ratings history on Facebook click here. For more ratings news on Facebook click here.
Shares of Facebook closed at $29.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- Canaccord Upgrades HLS Therapeutics (HLS:CN) (HLTRF) to Buy
- Google execs convened 'all-hands' meeting last week to address AI unit reorganizations amid staff concerns - Reuters
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
